Thomas Clayton

2.0k total citations
6 papers, 166 citations indexed

About

Thomas Clayton is a scholar working on Molecular Biology, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas Clayton has authored 6 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas Clayton's work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Thomas Clayton is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Thomas Clayton collaborates with scholars based in United States, Switzerland and Australia. Thomas Clayton's co-authors include Philip P. Chamberlain, Xinde Zheng, Gang Lu, Mary E. Matyskiela, Eileen Tran, Lawrence G. Hamann, Barbra Pagarigan, Mark Rolfe, Christopher G. Mayne and Joseph J. McDonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Structural & Molecular Biology and BioTechniques.

In The Last Decade

Thomas Clayton

6 papers receiving 165 citations

Peers

Thomas Clayton
Elizabeth C. Townsend United States
Shih Chieh Chang United States
Adam G. Bond United Kingdom
Enes Ugur Germany
Jason X. Tang United States
Marsha L. Mason United States
J. Grace Shaw United States
Joseph D. Garlick United States
Elizabeth C. Townsend United States
Thomas Clayton
Citations per year, relative to Thomas Clayton Thomas Clayton (= 1×) peers Elizabeth C. Townsend

Countries citing papers authored by Thomas Clayton

Since Specialization
Citations

This map shows the geographic impact of Thomas Clayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Clayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Clayton more than expected).

Fields of papers citing papers by Thomas Clayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Clayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Clayton. The network helps show where Thomas Clayton may publish in the future.

Co-authorship network of co-authors of Thomas Clayton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Clayton. A scholar is included among the top collaborators of Thomas Clayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Clayton. Thomas Clayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Thompson, Joel W., Thomas Clayton, Gody Khambatta, et al.. (2021). Profiling CELMoD-Mediated Degradation of Cereblon Neosubstrates. Methods in molecular biology. 2365. 283–300. 4 indexed citations
2.
Clayton, Thomas, et al.. (2021). Abnormal movements and diaphragmatic flutter in a case of suspected induced illness. BMJ Case Reports. 14(4). e236962–e236962. 1 indexed citations
3.
Matyskiela, Mary E., Thomas Clayton, Xinde Zheng, et al.. (2020). Crystal structure of the SALL4–pomalidomide–cereblon–DDB1 complex. Nature Structural & Molecular Biology. 27(4). 319–322. 65 indexed citations
4.
Matyskiela, Mary E., J. Zhu, Joshua M. Baughman, et al.. (2020). Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural Degrons. ACS Chemical Biology. 15(12). 3149–3158. 30 indexed citations
5.
Hayashi, Yohei, Laura Caboni, Debanu Das, et al.. (2015). Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Proceedings of the National Academy of Sciences. 112(15). 4666–4671. 40 indexed citations
6.
Page, Rebecca, Kin Moy, Jeffrey Velasquez, et al.. (2004). Scalable High-Throughput Micro-Expression Device for Recombinant Proteins. BioTechniques. 37(3). 364–370. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026